Compound Summary
Compound Information
chlormezanone
Compound Name: | chlormezanone |
Compound CID: | 2717 |
Synonyms: | chlormezanone 80-77-3 Chlormethazanone Trancopal Chlormethazone More... |
Iupac Name: | 2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one |
InChI: | InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3 |
InChIKey: | WEQAYVWKMWHEJO-UHFFFAOYSA-N |
Canonical Smiles: | CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl |
Isomeric Smiles: | CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl |
Molecular Weight: | 273.74 |
Molecular Formula: | C11H12ClNO3S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
chlormezanone
Molecular Weight: | 273.74 |
Molecular Formula: | C11H12ClNO3S |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 17 |
Complexity: | 395 |
Synonyms
chlormezanone
| chlormezanone | chlormezanone |
|---|---|
chlormezanone |
80-77-3 |
Chlormethazanone |
Trancopal |
Chlormethazone |
Chlormezanon |
Clormetazanone |
Clormetazon |
Phenarol |
dl-Chlormezanone |
Clorilax |
Miorilax |
Myolespen |
Rilansyl |
Rilaquil |
Rilassol |
Supotran |
Trancote |
Alinam |
Banabin |
Bisina |
Tanafol |
Rexan |
Rilax |
Banabin-sintyal |
Muskel-Trancopal |
Mio-sed |
Banabil-sintyal |
2-(4-Chlorophenyl)-3-methyl-1,3-thiazinan-4-one 1,1-dioxide |
Chlormezanonum |
Dichloromezanone |
Clormezanone DCIT |
Chlomedinon |
Rillasol |
Suprotan |
Muskel |
Lobak |
(+-)-Chlormezanone |
Chlormezanonum INN-Latin |
Clormezanona INN-Spanish |
Dichloromethazanone |
2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one |
WIN 4692 |
2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide |
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide |
2-(4-Chlorophenyl)-3-methyl-4-metathiazanone-1,1-dioxide |
2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide |
Chlormezanone (Trancopal) |
Tranrilax |
UNII-4BU37OM8KL |
4BU37OM8KL |
UNII-C14WB33Y0S |
4H-1,3-Thiazin-4-one, tetrahydro-2-(p-chlorophenyl)-3-methyl-, 1,1-dioxide |
C14WB33Y0S |
CHEBI:3619 |
Clormezanone |
2-(4-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide |
NCGC00015191-06 |
NCGC00015191-07 |
Clormezanona |
Rilasol |
Transanate |
(+-)-Fenarol |
DSSTox_CID_2798 |
DSSTox_RID_76732 |
DSSTox_GSID_22798 |
chlormezanona |
Chlormezanone BAN:INN:JAN |
Chlormezanone INN:BAN:JAN |
MFCD00143951 |
SMR001456219 |
HSDB 3300 |
SR-01000075208 |
TRANCOPAL (TN) |
EINECS 201-307-4 |
Chlormezanone (JAN/INN) |
NSC 169108 |
Fenaprim |
Trancopa |
2-(4-Chlorphenyl)-3-methyl-4-metathiazanon-1,1-dioxid |
CAS-80-77-3 |
4H-1,3-Thiazin-4-one, 2-(p-chlorophenyl)tetrahydro-3-methyl-1,1-dioxide |
Prestwick_736 |
(+)-Chlormezanone |
(-)-Chlormezanone |
2-(para-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one, 1,1-dioxide |
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-1,1-dioxide |
(+)-Fenarol |
(-)-Fenarol |
(+/-)-chlormezanone |
Chlormezanone, (+)- |
Chlormezanone, (-)- |
Spectrum_000414 |
(.+/-.)-Fenarol |
Prestwick0_000336 |
Prestwick1_000336 |
Prestwick2_000336 |
Prestwick3_000336 |
Spectrum2_001807 |
Spectrum3_001084 |
Spectrum4_001237 |
Spectrum5_001364 |
C-192 |
(.+/-.)-Chlormezanone |
Biomol-NT_000277 |
Lopac0_000383 |
Oprea1_275911 |
BSPBio_000371 |
BSPBio_002728 |
KBioGR_001734 |
KBioSS_000894 |
CHLORMEZANONE TRANCOPAL |
MLS003876813 |
MLS004773972 |
DivK1c_000886 |
SCHEMBL217864 |
SPECTRUM2300062 |
SPBio_001793 |
SPBio_002292 |
BPBio1_000409 |
BPBio1_001189 |
GTPL7323 |
CHEMBL1200714 |
DTXSID3022798 |
HMS502M08 |
KBio1_000886 |
KBio2_000894 |
KBio2_003462 |
KBio2_006030 |
KBio3_001948 |
WEQAYVWKMWHEJO-UHFFFAOYSA- |
NINDS_000886 |
HMS1569C13 |
HMS2096C13 |
HMS3261M07 |
HMS3266A22 |
HMS3411M15 |
HMS3655N09 |
HMS3675M15 |
HMS3713C13 |
HMS3884E20 |
Pharmakon1600-02300062 |
BCP14385 |
HY-B0353 |
WLN: T6VN DSWTJ B1 CR DG |
Tox21_110093 |
Tox21_113151 |
Tox21_302197 |
Tox21_500383 |
CCG-39616 |
NSC169108 |
NSC759569 |
s2021 |
Chlormezanone 1.0 mg/ml in Methanol |
4H-1,3-Thiazin-4-one, 2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide |
AKOS000121464 |
AKOS016844064 |
Tox21_110093_1 |
DB01178 |
LP00383 |
NSC-169108 |
NSC-759569 |
SDCCGSBI-0050370.P004 |
Chlormezanone 100 microg/mL in Ethanol |
IDI1_000886 |
NCGC00015191-03 |
NCGC00015191-04 |
NCGC00015191-05 |
NCGC00015191-08 |
NCGC00015191-09 |
NCGC00015191-10 |
NCGC00015191-13 |
NCGC00015191-22 |
NCGC00024597-02 |
NCGC00024597-03 |
NCGC00024597-04 |
NCGC00024597-05 |
NCGC00024597-06 |
NCGC00255305-01 |
NCGC00261068-01 |
2-(p-Chlorphenyl)-3-methyl-1,1-dioxide |
SBI-0050370.P003 |
AB00052410 |
EU-0100383 |
FT-0623609 |
SW196880-3 |
C76585 |
D00268 |
AB00052410_04 |
AB00052410_05 |
Q5102983 |
SR-01000075208-1 |
SR-01000075208-3 |
SR-01000075208-5 |
SR-01000075208-6 |
BRD-A20348246-001-05-9 |
BRD-A20348246-001-08-3 |
2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,1-dioxide |
Z271004890 |
4H-1, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide |
4H-1, 2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide |
2-(4-chlorophenyl)-3-methyl-1lambda6,3-thiazinane-1,1,4-trione |
2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-one, 1,1-dioxide |
2-(4-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one-1,1-dioxide |
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide, (+)- |
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide, (-)- |
102818-66-6 |
102818-67-7 |
Experimental Data
chlormezanone
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -5 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
chlormezanone
Statistics Data
chlormezanone
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -5 | 1 | 1 |
Statistics Data Visualization
chlormezanone
